This paper investigates whether joint ventures and strategic alliances create value for bondholders by examining the bond market’s reaction to announcements of these two types of cooperative business activities. Based on 2964 announcements from 1985 to 2011, we find that joint ventures and strategic alliances create significant value for bondholders. The average two-month abnormal bond return i...

International Construction firms have extensively used joint ventures as a vehicle to enter new construction markets in South East Asia since the early seventies. Despite its immense popularity, the failure rate of such ventures has been quite alarming. While extensive research has been carried out in the manufacturing and service industries in determining the factors that influence the perform...

With the demise of the Colombian cartels in the late 1980s, a new business paradigm has emerged in Colombia and other Latin American countries. Throughout the last several decades, numerous political, social, and economic factors have aided in the emergence and growth of this new illicit venture. Internally, illicit ventures are shaped by the state’s increased dependence on the illicit drug tra...

innovation is the key to organizational survival and therefore, it seems necessary to study and identify its affecting factors such as intellectual capital as one of the most important of new organizational intangible assets. considering the importance of this issue, the main purpose of this research was to study the effect of intellectual capital on organizational innovation in the agricultura...

When organizations adopt new practices, the practices are often modified to fit the new context. We argue that managers who implement new practices modify them, and that the extent of practice variation is determined by two types of these managers’ career experience: experience with the practice itself and experience that enables assessment of the fit between the practice and the adopting firm....

The international competitiveness of Japan in drug discovery is low. Among the companies responsible for discovering new drugs approved by US Food and Drug Administration (FDA) from 2017 to 2021, United States Europe, bio-ventures established 1990s or later accounted approximately half one-third total. In contrast, all originated Japanese were discovered long-established pharmaceutical companie...